How long will it take a car to accelerate from 20 m/s to 26 m/s at a rate of 1.4 m/s2?

Select the correct answer from each drop-down menu. compared to its surroundings, the concentration of solutes is low inside a cell. so, the cell is with respect to its surroundings. a particular solute in this cell uses energy for its transport from the cell to its surroundings. this type of transport is called

Chapter 23, problem 075 the figure shows a geiger counter, a device used to detect ionizing radiation (radiation that causes ionization of atoms). the counter consists of a thin, positively charged central wire surrounded by a concentric, circular, conducting cylindrical shell with an equal negative charge. thus, a strong radial electric field is set up inside the shell. the shell contains a low-pressure inert gas. a particle of radiation entering the device through the shell wall ionizes a few of the gas atoms. the resulting free electrons (e) are drawn to the positive wire. however, the electric field is so intense that, between collisions with gas atoms, the free electrons gain energy sufficient to ionize these atoms also. more free electrons are thereby created, and the process is repeated until the electrons reach the wire. the resulting "avalanche" of electrons is collected by the wire, generating a signal that is used to record the passage of the original particle of radiation. suppose the radius of the central wire is 24 âµm, the inner radius of the shell 2.3 cm, and the length of the shell 14 cm. if the electric field at the shell's inner wall is 2.8 ă— 104 n/c, what is the total positive charge on the central wire?

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience. b. report the adverse drug experience to the irb only if there are several other occurrences. c. report the adverse drug experience as part of the continuing review report. d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.